Weight loss jabs could significantly lower the risk of breast cancer , even in those considered at high risk of the disease, a landmark study has suggested.

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.…

Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease